DISCONTINUED OPERATIONS (Revenues and Net Income (Loss)) (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Sep. 30, 2015	Dec. 31, 2016	Dec. 31, 2015
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Impairment of long-lived assets	$ 7,000
Income (loss) from discontinued operations		$ 653	$ (23,092)
Genetic Assays and Platforms and Patient Testing | Included in assets held for sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net sales		2,163	18,308
Cost of goods sold		574	12,287
Gross profit		1,589	6,021
Selling, general and administrative expense		1,710	15,187
Research and development expense		167	408
Impairment of long-lived assets		0	13,942
Operating income (loss) from discontinued operations		(288)	(23,516)
Gain on settlement of accounts payable		325	0
Gain (loss) on sale of assets/business		1,047	(224)
Income (loss) from discontinued operations before income taxes		1,084	(23,740)
Income tax expense (benefit)		431	(648)
Income (loss) from discontinued operations		653	$ (23,092)
Patient Testing | Included in assets held for sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Gain on settlement of accounts payable		300
Income (loss) from discontinued operations		$ 1,000